| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
| Chain A, Retinaldehyde-binding protein 1 | 0 | 0 | 1 | 1 |
| TDP1 protein | 6 | 0 | 0 | 6 |
| aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
| core protein, partial | 0 | 1 | 0 | 1 |
| geminin | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
| Bile salt export pump | 0 | 5 | 0 | 5 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
| GLS protein | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
| AR protein | 9 | 0 | 0 | 9 |
| nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
| glucocorticoid receptor [Homo sapiens] | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
| retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
| estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
| estrogen nuclear receptor alpha | 11 | 0 | 0 | 11 |
| euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
| Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
| Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 3 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 3 | 1 | 7 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 3 | 0 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 5 | 0 | 0 | 5 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 4 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 1 | 4 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 1 | 4 |
| Adenosine receptor A2a | 0 | 2 | 0 | 5 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 4 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 5 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 4 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 5 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 3 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 4 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 4 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Luciferase | 5 | 0 | 0 | 5 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| G | 3 | 0 | 0 | 3 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 2 | 1 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 1 | 3 |
| Interferon beta | 3 | 0 | 0 | 3 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Fatty acid-binding protein, liver | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 1 | 0 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 1 | 0 | 3 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 1 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Cruzipain | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 1 | 0 | 3 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 1 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 1 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 1 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Peroxisome proliferator-activated receptor alpha | 0 | 1 | 1 | 2 |
| GABA theta subunit | 2 | 1 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 2 | 1 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| thioredoxin reductase | 2 | 0 | 0 | 2 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| 67.9K protein | 1 | 0 | 0 | 1 |
| peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
| IDH1 | 2 | 0 | 0 | 2 |
| Histone H2A.x | 4 | 0 | 0 | 4 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| Vpr | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
| Amyloid-beta precursor protein | 1 | 1 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| Chain A, ELONGATION FACTOR TU (EF-TU) | 0 | 0 | 1 | 1 |
| Chain A, Elongation Factor G | 0 | 0 | 1 | 1 |
| Chain A, ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 3 | 0 | 0 | 1 | 1 |
| Chain A, Eukaryotic peptide chain release factor GTP-binding subunit | 0 | 0 | 1 | 1 |
| Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b | 0 | 0 | 1 | 1 |
| Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b | 0 | 0 | 1 | 1 |
| Chain A, interferon-inducible GTPase | 0 | 0 | 1 | 1 |
| Chain A, interferon-inducible GTPase | 0 | 0 | 1 | 1 |
| Chain A, Elongation factor 2 | 0 | 0 | 1 | 1 |
| Chain A, Guanine nucleotide-binding protein G(i), alpha-1 subunit | 0 | 0 | 1 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Matrilysin | 0 | 1 | 0 | 1 |
| 2-dehydropantoate 2-reductase | 0 | 0 | 1 | 1 |
| Ras-related protein Rab-7a | 0 | 0 | 1 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 | 0 | 1 | 0 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 | 0 | 2 | 0 | 2 |
| retinoic acid receptor alpha isoform 1 | 0 | 1 | 0 | 1 |
| retinoic acid receptor RXR-alpha isoform a | 0 | 1 | 0 | 1 |
| Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
| Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
| Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| Chain A, Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Chain A, Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B10 | 0 | 0 | 0 | 2 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 0 | 0 | 1 |
| Alpha-synuclein | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 1 | 0 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 2 |
| Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 2 |
| Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
| SLC16A10 protein | 0 | 0 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 2 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 2 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 2 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
| Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
| Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |